BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1937 related articles for article (PubMed ID: 18687415)

  • 21. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
    Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
    Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosis.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Yamada H; Kawada N; Kawabata K
    Calcif Tissue Int; 2014 Aug; 95(2):166-73. PubMed ID: 24903232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate.
    Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T
    J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of Antiresorptive Action in Withdrawal of Minodronic Acid for Three Months After Treatment for Twelve Months in Ovariectomized Rats.
    Tanaka M; Mori H; Kawabata K
    Calcif Tissue Int; 2015 Oct; 97(4):402-11. PubMed ID: 26048283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of exercise and propranolol on bone tissue in ovariectomized rats.
    Bonnet N; Beaupied H; Vico L; Dolleans E; Laroche N; Courteix D; Benhamou CL
    J Bone Miner Res; 2007 Apr; 22(4):578-88. PubMed ID: 17243867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
    Iwamoto J; Seki A; Sato Y
    Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats.
    Osterman T; Laurén L; Kuurtamo P; Hannuniemi R; Isaksson P; Kippo K; Peng Z; Väänänen HK; Sellman R
    J Pharmacol Exp Ther; 1998 Jan; 284(1):312-6. PubMed ID: 9435193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of 1 alpha(OH)D3 on trabecular and cortical bone in ovariectomized rats].
    Xia W; Meng X; Xing X; Hu Y; Liu H; Zhou X; Qiu G; Yang X; Shen V; Wu D; Dempster D; Lindsay R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):543-7. PubMed ID: 12903400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat.
    Lane NE; Haupt D; Kimmel DB; Modin G; Kinney JH
    J Bone Miner Res; 1999 Feb; 14(2):206-14. PubMed ID: 9933474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
    Bone; 2016 May; 86():43-52. PubMed ID: 26921823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.
    Takeda S; Smith SY; Tamura T; Saito H; Takahashi F; Samadfam R; Haile S; Doyle N; Endo K
    Calcif Tissue Int; 2015 Jan; 96(1):45-55. PubMed ID: 25467010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation.
    Oxlund H; Andreassen TT
    Bone; 2004 Apr; 34(4):609-18. PubMed ID: 15050891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
    Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
    J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
    Ominsky MS; Li X; Asuncion FJ; Barrero M; Warmington KS; Dwyer D; Stolina M; Geng Z; Grisanti M; Tan HL; Corbin T; McCabe J; Simonet WS; Ke HZ; Kostenuik PJ
    J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 97.